<DOC>
	<DOC>NCT01392846</DOC>
	<brief_summary>This is a prospective, observational, cohort study to evaluate the relative efficacy and safety of Resolute Integrity stent compared to other (drug eluting stents) DES.</brief_summary>
	<brief_title>The IRIS-Resolute Integrity (IRIS-Integrity)</brief_title>
	<detailed_description>Consecutive Percutaneous Coronary Intervention patients receiving Resolute Integrity stent will be compared with other concurrent Drug Eluting Stents.</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients with significant coronary artery disease and receiving Resolute Integrity stent. The patient or guardian agrees to the study protocol and the schedule of clinical followup, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Patients with a mixture of other DESs Terminal illness with life expectancy &lt;1 year Patients presented with cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Coronary artery disease requiring drug eluting stents</keyword>
</DOC>